image_pdfimage_print

Akseli Kivioja and Satu Rauhala: stronger service portfolio at ESiOR

Posted Posted in News

Well-known Market Access professionals, Satu Rauhala and Akseli Kivioja, joined ESiOR on August 7th, 2017. Their joint experience is unique: Finnish Pharmaceuticals Pricing Board, pharma industry, pharmaceutical research, and consultancy. When you are in need of experience, expertise and broad vision, please don’t hesitate to contact us. Additional information: Akseli Kivioja, Satu Rauhala or Erkki Soini

Paid and unpaid work lost, hidden costs

Posted Posted in Publications

The hidden costs of impairments in working ability and functional capacity among Finnish patients with inflammatory bowel diseases and rheumatoid arthritis were assessed in a collaborative effort by ESiOR Oy, Abbvie Oy, The Crohn and Colitis association (Crohn ja Colitis ry), Confederation of Finnish Industries (EK), The Finnish Medical Association, The Finnish Rheumatism Association, SITRA, […]

RRMS: Considerable differences in the cost effectiveness of treatments

Posted Posted in Publications

Multiple sclerosis (MS) progression and the cost-effectiveness analysis of first line disease modifying MS treatments (DMT) in Finland ESiOR studied relapsing-remitting MS (RRMS) progression and cost of relapses based on visualization and analysis of Finnish patient-level MS register real-world (RWD) data. The real-world treatment path evidence (RWE) and costs were synthesized with e.g. DMT efficacy […]

Professor pharmacoeconomics

Posted Posted in News

Janne Martikainen, PhD (health economics), Adjunct Professor (economic evaluation of pharmaceuticals) in Turku University and one of ESiOR’s health economists and partners is now also the new Professor of pharmacoeconomics in the University of Eastern Finland.

Development project

Posted Posted in News

Development of business and services portfolio Project’s goals are to innovate and develop new business, support business growth and strengthen national and international competitiveness of the company. The project results in a growth company with significantly more versatile portfolio of business services and products targeted to a significantly wider spectrum of clients. In addition, the […]

Nordic RWD conference, meet us there

Posted Posted in News

ESiOR Ltd takes part in Nordic conference on Real World Data – Collaboration between pharma industry and Academia on November 29-30, 2016, in Helsinki. We have waited for the event with great interest, because we feel that Expert Solutions in Outcomes Research (ESiOR) has a lot to offer. Real world data (RWD) can depict what […]

New information on atrial fibrillation and anticoagulation

Posted Posted in Publications

A large proportion of patients with atrial fibrillation (AF) do not attain the treatment targets with traditional warfarin treatment. As a result, they remain at increased risk for AF-related events (stroke, hemorrhage) and other warfarin treatment associated adversities. Regardless of treatment balance, warfarin treatment causes significant monitoring costs making it worthwhile to study alternative treatments. […]

Essential ESiOR: 5 presentations at ISPOR

Posted Posted in News

It is time for celebration. ESiOR will participate in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Vienna for the tenth time. ISPOR is a must for everyone interested in pharmacoeconomics and outcomes research. Let’s meet in the congress! Ongoing regional government reform and social welfare and healthcare (SOTE) reform will […]

4th Nordic Conference on Research in Patient Safety and Quality in Healthcare

Posted Posted in News

ESiOR Oy participates in the 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare 19th-20th May 2016 in Hotel Puijonsarvi, Kuopio. We will be very pleased  to meet you there! Our expertise in social and healthcare sector include e.g. the following assessments : costs, effectiveness, cost-effectiveness, budget impact, patient paths and processes. Our services […]